glp 1 medication retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide vs Tirzepatide (2026): Differences
Description
Flexible Medication Formats: The ability to choose between dissolvable tablets and injections is a genuine differentiator
Doctors consider colonoscopy the best test to allow both diagnosis and treatment at the same time
When pharma analysts spoke about crossing into rarefied air earlier this year, few predicted how quickly it would happen
The effect is usually temporary and manageable with targeted hydration strategies
Food and Drug Administration for the management of type 2 diabetes, weight management, and cardiovascular risk reduction
